newsfilter
← Latest News
PR Newswire·

TDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards Merger

  • Translational Development Acquisition Company (TDAC) announced that ProLogium filed its initial F-4 registration statement with the SEC.
  • This filing advances the de-SPAC merger transaction originally announced on May 27, 2026.
  • The F-4 document provides investors with a detailed history of ProLogium & additional data regarding the merger terms.
  • TDAC Chairman & CEO Michael Hoffman stated the filing offers significant insight into the company & the transaction.
  • The filing remains subject to SEC review & may be revised before final approval.
  • The press release includes extensive forward-looking statements warning of risks such as shareholder redemptions, regulatory hurdles, technology commercialization challenges, & potential tariff disputes.
  • Specific risks include the failure to meet the $250 million minimum cash condition, obtaining shareholder approval, & maintaining stock exchange listing standards.
  • Neither ProLogium nor TDAC assumes a duty to update these forward-looking statements after the July 6, 2026 communication date.